Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1027831]Researchers: Prof Richard Lock (Principal investigator) , Dr Greg Arndt , Prof John Pimanda
Brief description Glucocorticoids are among the most effective drugs used in the treatment of many haematological malignancies, including leukaemia, lymphoma and multiple myeloma. However, the development of tumour cell resistance to these drugs remains a significant problem, and clinically relevant mechanisms of glucocorticoid resistance remain poorly understood. This project aims to define mechanisms of resistance to glucocorticoids and develop new drugs to reverse resistance.
Funding Amount $AUD 394,721.45
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1027831
- PURL : https://purl.org/au-research/grants/nhmrc/1027831
